ICARES Medicus (ROCO:6612) Short-Term Debt: NT$653 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:6612 ICARES Medicus Inc ROCO:6612
87 GF Score
Price NT$71.00
GF Value NT$152.06
Valuation Significantly Undervalued
! 7 Warning Signs
View Full Analysis

What is ICARES Medicus Short-Term Debt?

ICARES Medicus ROCO:6612 +0.57% 87 Short-Term Debt is NT$653 Mil as of Jun. 2026. GuruFocus rates ROCO:6612 with a GF Score™ of 87/100 and a GF Value™ of NT$152.06 (Significantly Undervalued). The stock has 7 warning signs investors should review.

ICARES Medicus's Short-Term Debt for the quarter that ended in Jun. 2026 was NT$653 Mil.

ICARES Medicus's quarterly Short-Term Debt declined from Dec. 2025 (NT$611 Mil) to Mar. 2026 (NT$584 Mil) but then increased from Mar. 2026 (NT$584 Mil) to Jun. 2026 (NT$653 Mil).

ICARES Medicus's annual Short-Term Debt increased from Dec. 2023 (NT$0 Mil) to Dec. 2024 (NT$385 Mil) and increased from Dec. 2024 (NT$385 Mil) to Dec. 2025 (NT$611 Mil).

ICARES Medicus Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

ICARES Medicus Short-Term Debt Related Terms

ICARES Medicus Short-Term Debt Historical Data

* Premium members only.

The historical data trend for ICARES Medicus's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ICARES Medicus Short-Term Debt Chart

ICARES Medicus Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Short-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 385.35 611.34

ICARES Medicus Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Short-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 579.19 631.55 611.34 584.22 653.41
ROCO:6612
87GF Score
ICARES Medicus Inc ROCO:6612
Short-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Short-Term Debt →
What does a Short-Term Debt of NT$653 Mil mean?
ICARES Medicus (ROCO:6612) has a Short-Term Debt of NT$653 Mil as of Jun. 2026.
Is ICARES Medicus' Short-Term Debt too high?
ICARES Medicus' current Short-Term Debt is NT$653 Mil. Overall, ICARES Medicus has a GF Score™ of 87/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does ICARES Medicus' Short-Term Debt compare to ISRG and BDX?
ICARES Medicus' Short-Term Debt of NT$653 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Short-Term Debt for a Medical Devices & Instruments company?
A good Short-Term Debt depends on the Medical Devices & Instruments industry context. However, Short-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Short-Term Debt mean?
A high Short-Term Debt can signal that a stock is expensive relative to its fundamentals. ICARES Medicus's current Short-Term Debt is NT$653 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ICARES Medicus stock overvalued right now?
Based on GuruFocus' analysis, ICARES Medicus (ROCO:6612) is currently considered Significantly Undervalued. The stock's GF Value™ is NT$152.06, compared to a current price of NT$71.00 — trading 53.3% below its estimated fair value. The current Short-Term Debt is NT$653 Mil. ICARES Medicus' overall GF Score™ is 87/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Short-Term Debt calculated?
Short-Term Debt is calculated from a company's financial statements. For ICARES Medicus (ROCO:6612), the current Short-Term Debt is NT$653 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is ICARES Medicus (ROCO:6612) Overvalued in 2026?

Based on GuruFocus' analysis, ICARES Medicus stock appears to be undervalued. The current stock price of NT$71.00 is trading 53.3% below its estimated GF Value™ of NT$152.06. GuruFocus considers ICARES Medicus to be Significantly Undervalued.

Key valuation signals for ROCO:6612:

  • Short-Term Debt: NT$653 Mil
  • GF Value™: NT$152.06 vs. price of NT$71.00 (53.3% below fair value)
  • GF Score™: 87/100 with 7 warning signs

No single metric tells the full story. See the ROCO:6612 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

ICARES Medicus Business Description

Address Section 2, Shengyi Road, No. 16, 4th Floor, Hsinchu County, Zhubei, TWN, 30261
ICARES Medicus Inc is engaged in providing high-grade nanomedical lubricious coatings and various surface treatments for implantable or interventional medical devices. In addition, it also designs, develops, manufactures, and sells intraocular lenses and nanomedical devices. The company's operating segments are Europe and America, which derive maximum revenue, China, and R.O.C. Geographically, it generates maximum revenue from the United States, followed by Taiwan, Spain, England, Japan, China, Germany, and other countries.
87GF Score

Get the complete analysis for ROCO:6612

Short-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$71.00
Price
NT$152.06
GF Value